Adam Michael

Adam Michael is an experienced communications professional and director, currently serving as the Director of Investor Relations & Communications (Fractional) at Ambrose Healthcare Ltd since February 2023. Adam has a strong background in life sciences, having founded and directed 80th Atom while leading communications at various organizations such as Cytox Limited, Atlantic Healthcare plc, Abchurch Communications, and College Hill. Adam's expertise spans corporate messaging, investor relations, media relations, and business development, particularly focusing on pharmaceutical solutions for rare diseases and unmet medical needs. Adam holds a BSc in Applied Biology from the University of Hull and has completed journalist training.